Pharmaceutical

Signal: Serum Institute of India plans to increase glob...

Serum Institute of India, a vaccine manufacturer, has historically focused on s...

TREAT California embarks on plan to earn $5bn for psych...

A nonprofit in California has started a major signature campaign for a November...

Twist Bioscience and Bayer partner for antibody discovery

Genomics company Twist Bioscience has entered an antibody discovery, option and...

AbbVie to bolster neuroscience pipeline with Mitokinin ...

AbbVie has acquired discovery-stage biotechnology company Mitokinin in a $655m ...

STAT+: Inflammation gets its own research center, thank...

A New Chan Zuckerberg Biohub in Chicago will focus on inflammation, starting wit...

STAT+: Judge dismisses Novo Nordisk lawsuit over compou...

In a setback for Novo Nordisk, a U.S. judge dismissed its lawsuit accusing a com...

STAT+: Long underappreciated, gamma-delta T cells may b...

New research suggests an understudied immune cell, the gamma-delta T cell, has s...

NIH funds expanded access projects for ALS

Want to stay on top of the science and politics driving biotech today? Sign up t...

STAT+: Pharmalittle: FDA panel lacks confidence in Amge...

A FDA advisory panel voted 10-2 that the data for Amgen's Lumakras lung cancer t...

Opinion: STAT+: How payer-participating trials could he...

Earlier this year, the FDA commissioner proposed something radical — payer-parti...

Opinion: The next frontier in biomedicine: AI models of...

The next frontier in biomedicine: AI models of the human immune system, write Wa...

Access to new tools to combat RSV in babies likely to p...

Access to new tools to combat RSV is likely to prove challenging this season, ex...

Medicare’s proposal on nursing home staff is ‘insanity,...

Medicare experts think the Biden administration’s plan for stricter nursing home...

What’s on tap at HLTH, the health care industry jambore...

What's on tap at HLTH, the health care industry jamboree that kicks off this wee...

STAT+: FDA advisory panel signals lack of confidence in...

The clearance of a first-of-its-kind cancer treatment made by Amgen is on shakie...

FDA expert panel endorses idea of removing a component ...

The FDA's expert vaccine advisory panel unanimously endorsed the idea of taking ...